Market Tracker

03/29 4:56am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.93
Delayed Data
As of Mar 28
 -0.05 / -0.84%
Today’s Change
4.03
Today|||52-Week Range
7.80
+1.19%
Year-to-Date

Today’s Trading

Previous close5.98
Today’s open6.01
Day’s range5.72 - 6.05
Volume955,888
Average volume (3 months)1,470,924
Market cap$643.9M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-27.73%
Earnings growth (this year)+55.13%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+133.79%
P/E ratioNM
Price/Sales19.39
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.15-1.04%
AMPHAmphastar Pharmaceut...+0.36+2.52%
ARDXArdelyx Inc-0.35-2.62%
ACIUAC Immune Ltd+0.49+4.40%
Data as of 03/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$32.0M
Annual profit (last year)-$161.1M
Net profit margin-503.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts